Mutant p53 drives the loss of heterozygosity by the upregulation of Nek2 in breast cancer cells. Ghaleb A, Padellan M, Marchenko N. Breast Cancer Res 2020;22:133.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Ghaleb A, Padellan M, Marchenko N. Mutant p53 drives the loss of heterozygosity by the upregulation of Nek2 in breast cancer cells. Breast Cancer Res 2020;22:133.
PMID: 33267874